Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study

Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study

Importance: The use of anticoagulant therapy with heparins decreased mortality in hospitalized patients with severe coronavirus disease 2019 (COVID-19). Even if enoxaparin and fondaparinux have the same clinical indication for venous thromboembolism (VTE) prevention; to date, there are no data about...

Full description

Bibliographic Details
Main Authors: Vincenzo Russo, Giuseppe Cardillo, Giuseppe Vito Viggiano, Sara Mangiacapra, Antonella Cavalli, Andrea Fontanella, Federica Agrusta, Annamaria Bellizzi, Maria Amitrano, Mariateresa Iannuzzo, Clara Sacco, Corrado Lodigiani, Giampiero Castaldo, Pierpaolo Di Micco
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Medicine
Subjects:
COVID-19
fondaparinux
enoxaparin
major bleedings
thromboprofylaxis
pulmonary embolism
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.569567/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2020.569567/full

Similar Items